Antibiotic resistant mutants of Escherichia coli K12 show increases in heterologous gene expression
- PMID: 21087626
- DOI: 10.1016/j.plasmid.2010.11.004
Antibiotic resistant mutants of Escherichia coli K12 show increases in heterologous gene expression
Abstract
Using a variety of antibiotics, it was found that nine separate isolates of spontaneous antibiotic resistant mutants of Escherichia coli K12 pPSX-vioABCDE overproduce the anti-tumour antibiotic violacein. Subsequent analysis showed that seven of these mutations occurred on the plasmid pPSX-vioABCDE. The other two overproducing strains carried spontaneous chromosomal mutations to lincomycin and kanamycin. The kanamycin resistant mutant of E. coli K12 DH10B (AA23) and a lincomycin resistant mutant of E. coli K12 LE392 (AA24) increased the synthesis of violacein. The plasmid pPSX-vioABCDE opv-1 contains a violacein over-production (opv-1) mutation which when introduced into either E. coli K12 AA23 or AA24, resulted in a hyper-production of violacein. Remarkably, E. coli K12 AA23 pPSX-vioABCDE opv-1 produced 41 times the normal level of violacein. In addition, both E. coli K12 AA23 and E. coli K12 AA24 demonstrated an increase in expression of an alpha amylase gene from Streptomyces lividans and the urease gene cluster from Klebsiella oxytoca. These results suggest that selection of antibiotic resistant mutants can increase heterologous gene expression in E. coli K12. Additionally, the increased expression is a general effect applicable to genes and gene clusters cloned into E. coli K12 from both Gram-positive and Gram-negative bacteria.
Copyright © 2010 Elsevier Inc. All rights reserved.
Similar articles
-
Stable high level expression of the violacein indolocarbazole anti-tumour gene cluster and the Streptomyces lividans amyA gene in E. coli K12.Plasmid. 2010 Mar;63(2):79-85. doi: 10.1016/j.plasmid.2009.11.004. Epub 2009 Dec 3. Plasmid. 2010. PMID: 19962399
-
Plasmid encoded antibiotics inhibit protozoan predation of Escherichia coli K12.Plasmid. 2011 Sep;66(3):152-8. doi: 10.1016/j.plasmid.2011.07.006. Epub 2011 Aug 3. Plasmid. 2011. PMID: 21839110
-
pPSX: a novel vector for the cloning and heterologous expression of antitumor antibiotic gene clusters.Plasmid. 2007 May;57(3):306-13. doi: 10.1016/j.plasmid.2006.11.004. Epub 2007 Jan 10. Plasmid. 2007. PMID: 17218012
-
Outer membrane proteomics of kanamycin-resistant Escherichia coli identified MipA as a novel antibiotic resistance-related protein.FEMS Microbiol Lett. 2015 Jun;362(11):fnv074. doi: 10.1093/femsle/fnv074. Epub 2015 May 3. FEMS Microbiol Lett. 2015. PMID: 25940639
-
Violacein: Properties and Production of a Versatile Bacterial Pigment.Biomed Res Int. 2015;2015:465056. doi: 10.1155/2015/465056. Epub 2015 Aug 3. Biomed Res Int. 2015. PMID: 26339614 Free PMC article. Review.
Cited by
-
Fighting microbial drug resistance: a primer on the role of evolutionary biology in public health.Evol Appl. 2015 Mar;8(3):211-22. doi: 10.1111/eva.12254. Epub 2015 Mar 23. Evol Appl. 2015. PMID: 25861380 Free PMC article.
-
New strategies for drug discovery: activation of silent or weakly expressed microbial gene clusters.Appl Microbiol Biotechnol. 2013 Jan;97(1):87-98. doi: 10.1007/s00253-012-4551-9. Epub 2012 Nov 11. Appl Microbiol Biotechnol. 2013. PMID: 23143535 Free PMC article. Review.
-
Functional characterization of a novel violacein biosynthesis operon from Janthinobacterium sp. B9-8.Appl Microbiol Biotechnol. 2022 Apr;106(8):2903-2916. doi: 10.1007/s00253-022-11929-8. Epub 2022 Apr 21. Appl Microbiol Biotechnol. 2022. PMID: 35445857
-
The Application of Ribosome Engineering to Natural Product Discovery and Yield Improvement in Streptomyces.Antibiotics (Basel). 2019 Aug 30;8(3):133. doi: 10.3390/antibiotics8030133. Antibiotics (Basel). 2019. PMID: 31480298 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical